SLLK, Control Peptide for TSP1 Inhibitor

Alternative_Names

Ser-Leu-Leu-Lys;SLLK
CAS

NA
MWt

459.59
Formula

C21H41N5O6
Solubility

H2O
Clinical_Information

No Development Reported
Pathway

Others
Target

Others
Datasheet
SDS
Description

Isotype or positive controls by peptides, antibodies and deactivated samples. Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme. Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.

Gene target

SLLK Peptide for TSP1 Inhibitor
Gene symbol

SPZ1, THBS1
Short name

SLLK, Control Peptide for TSP1 Inhibitor
Technique

Control, peptide, controls, peptides
Alternative name

SLLK, reference short protein sequence to measure TSP1 suppressor
Alternative technique

peptides, controls
Tissue

control